Conservative Balance Sheet / Low LeverageVery low leverage gives durable financial flexibility: the company can fund working-capital needs, weather sales volatility, and pursue opportunistic investments or contract wins without material refinancing risk, supporting stability over the next 2–6 months.

Positive Operating And Free Cash FlowConsistent positive cash generation and rising free cash flow improve self-funding ability for capex, R&D, or working capital. This cash buffer mitigates earnings swings and supports operational continuity and contract-manufacturing obligations long term.

Integrated Manufacturing And Contract-manufacturing ModelOwning manufacturing while serving third parties creates diversified revenue streams and captive capacity. This vertical capability supports margin stability, customer stickiness via contract relationships, and strategic flexibility to scale own brands or B2B volumes over time.

Bears Say

Sharp Revenue DeclineA steep near-term revenue drop reduces scale economics and risks underutilized manufacturing capacity. If sustained, lower volumes will pressure fixed-cost absorption and make margins and profitability harder to restore over the medium term absent new contract wins or product growth.

Low And Eroding Gross MarginsSub-10–12% gross margins limit operating leverage and leave little room to absorb input cost inflation or pricing pressure. Persistently thin gross profit reduces the firm's ability to rebuild earnings from revenue growth and heightens sensitivity to commodity or labor cost shifts.

Profitability Volatility / Modest ReturnsIntermittent losses and modest ROE indicate inconsistent earnings power. Such volatility impairs long-term reinvestment and makes it harder to execute strategic initiatives reliably; investors and counterparties may demand stronger proof of sustained profit recovery.

Integrated BioPharma News

Integrated BioPharma Holds 2025 Annual Stockholder Meeting

An update from Integrated BioPharma ( ($INBP) ) is now available. On December 1, 2025, Integrated BioPharma, Inc....

3M ago

INBP

Integrated BioPharma Secures New Credit Line with PNC

Integrated BioPharma ( ($INBP) ) has issued an update. On April 15, 2025, Integrated BioPharma, Inc. and its...

11M ago

INBP

INBP FAQ

What was Integrated BioPharma Inc’s price range in the past 12 months?

Integrated BioPharma Inc lowest stock price was $0.25 and its highest was $0.42 in the past 12 months.

What is Integrated BioPharma Inc’s market cap?

Integrated BioPharma Inc’s market cap is $8.85M.

When is Integrated BioPharma Inc’s upcoming earnings report date?

Integrated BioPharma Inc’s upcoming earnings report date is May 07, 2026 which is in 61 days.

How were Integrated BioPharma Inc’s earnings last quarter?

Integrated BioPharma Inc released its earnings results on Feb 11, 2026. The company reported -$0.024 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.024.

Is Integrated BioPharma Inc overvalued?

According to Wall Street analysts Integrated BioPharma Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Integrated BioPharma Inc pay dividends?

Integrated BioPharma Inc does not currently pay dividends.

What is Integrated BioPharma Inc’s EPS estimate?

Integrated BioPharma Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Integrated BioPharma Inc have?

Integrated BioPharma Inc has 31,059,610 shares outstanding.

What happened to Integrated BioPharma Inc’s price movement after its last earnings report?

Integrated BioPharma Inc reported an EPS of -$0.024 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3%.

Which hedge fund is a major shareholder of Integrated BioPharma Inc?

Currently, no hedge funds are holding shares in INBP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Integrated BioPharma Inc

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.